Cargando…
Utility of Combination Antimicrobial Therapy in Adults with Bloodstream Infections due to Enterobacteriaceae and Non-Fermenting Gram-Negative Bacilli Based on In Vitro Analysis at Two Community Hospitals
This study examined the utility of combination therapy for bloodstream isolates of Enterobacteriaceae and non-fermenting Gram-negative bacilli (NFGN) from adults at two community hospitals from January 2010 through to June 2015. Changes to in vitro antimicrobial susceptibilities by adding ciprofloxa...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466593/ https://www.ncbi.nlm.nih.gov/pubmed/30744080 http://dx.doi.org/10.3390/antibiotics8010015 |
_version_ | 1783411139732832256 |
---|---|
author | Foster, Rachel A. Troficanto, Casey Bookstaver, P. Brandon Kohn, Joseph Justo, Julie Ann Al-Hasan, Majdi N. |
author_facet | Foster, Rachel A. Troficanto, Casey Bookstaver, P. Brandon Kohn, Joseph Justo, Julie Ann Al-Hasan, Majdi N. |
author_sort | Foster, Rachel A. |
collection | PubMed |
description | This study examined the utility of combination therapy for bloodstream isolates of Enterobacteriaceae and non-fermenting Gram-negative bacilli (NFGN) from adults at two community hospitals from January 2010 through to June 2015. Changes to in vitro antimicrobial susceptibilities by adding ciprofloxacin or gentamicin to third-generation cephalosporins (3GC) were examined overall and in patients with risk factors for 3GC resistance. Overall ceftriaxone susceptibility among Enterobacteriaceae was 996/1063 (94%) and 247/295 (84%) in patients with 3GC resistance risk factors. Susceptibilities increased marginally by adding ciprofloxacin or gentamicin (mean difference 2.4% (95% CI 1.5, 3.4) and 3.0% (95% CI 2.0, 4.0), respectively, overall and 5.4% (95% CI 2.8, 8.0) and 7.1% (95% CI 4.2, 10.1), respectively, in patients with risk factors). Eighty-three of 105 (79%) NFGN were susceptible to ceftazidime overall and 20/29 (69%) in patients with prior beta-lactam use. Overall mean increase in susceptibilities was 15.2% (95% CI: 8.3, 22.2) and 17.1% (95% CI: 9.8, 24.5) for ciprofloxacin and gentamicin combinations, respectively; and 27.6% (95% CI: 10.3, 44.9) for either one with recent beta-lactam use. In this setting, empirical combination therapy had limited utility for Enterobacteriaceae bloodstream isolates but provided significant additional antimicrobial coverage to ceftazidime for NFGN, particularly in patients with prior beta-lactam use. |
format | Online Article Text |
id | pubmed-6466593 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-64665932019-04-18 Utility of Combination Antimicrobial Therapy in Adults with Bloodstream Infections due to Enterobacteriaceae and Non-Fermenting Gram-Negative Bacilli Based on In Vitro Analysis at Two Community Hospitals Foster, Rachel A. Troficanto, Casey Bookstaver, P. Brandon Kohn, Joseph Justo, Julie Ann Al-Hasan, Majdi N. Antibiotics (Basel) Article This study examined the utility of combination therapy for bloodstream isolates of Enterobacteriaceae and non-fermenting Gram-negative bacilli (NFGN) from adults at two community hospitals from January 2010 through to June 2015. Changes to in vitro antimicrobial susceptibilities by adding ciprofloxacin or gentamicin to third-generation cephalosporins (3GC) were examined overall and in patients with risk factors for 3GC resistance. Overall ceftriaxone susceptibility among Enterobacteriaceae was 996/1063 (94%) and 247/295 (84%) in patients with 3GC resistance risk factors. Susceptibilities increased marginally by adding ciprofloxacin or gentamicin (mean difference 2.4% (95% CI 1.5, 3.4) and 3.0% (95% CI 2.0, 4.0), respectively, overall and 5.4% (95% CI 2.8, 8.0) and 7.1% (95% CI 4.2, 10.1), respectively, in patients with risk factors). Eighty-three of 105 (79%) NFGN were susceptible to ceftazidime overall and 20/29 (69%) in patients with prior beta-lactam use. Overall mean increase in susceptibilities was 15.2% (95% CI: 8.3, 22.2) and 17.1% (95% CI: 9.8, 24.5) for ciprofloxacin and gentamicin combinations, respectively; and 27.6% (95% CI: 10.3, 44.9) for either one with recent beta-lactam use. In this setting, empirical combination therapy had limited utility for Enterobacteriaceae bloodstream isolates but provided significant additional antimicrobial coverage to ceftazidime for NFGN, particularly in patients with prior beta-lactam use. MDPI 2019-02-08 /pmc/articles/PMC6466593/ /pubmed/30744080 http://dx.doi.org/10.3390/antibiotics8010015 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Foster, Rachel A. Troficanto, Casey Bookstaver, P. Brandon Kohn, Joseph Justo, Julie Ann Al-Hasan, Majdi N. Utility of Combination Antimicrobial Therapy in Adults with Bloodstream Infections due to Enterobacteriaceae and Non-Fermenting Gram-Negative Bacilli Based on In Vitro Analysis at Two Community Hospitals |
title | Utility of Combination Antimicrobial Therapy in Adults with Bloodstream Infections due to Enterobacteriaceae and Non-Fermenting Gram-Negative Bacilli Based on In Vitro Analysis at Two Community Hospitals |
title_full | Utility of Combination Antimicrobial Therapy in Adults with Bloodstream Infections due to Enterobacteriaceae and Non-Fermenting Gram-Negative Bacilli Based on In Vitro Analysis at Two Community Hospitals |
title_fullStr | Utility of Combination Antimicrobial Therapy in Adults with Bloodstream Infections due to Enterobacteriaceae and Non-Fermenting Gram-Negative Bacilli Based on In Vitro Analysis at Two Community Hospitals |
title_full_unstemmed | Utility of Combination Antimicrobial Therapy in Adults with Bloodstream Infections due to Enterobacteriaceae and Non-Fermenting Gram-Negative Bacilli Based on In Vitro Analysis at Two Community Hospitals |
title_short | Utility of Combination Antimicrobial Therapy in Adults with Bloodstream Infections due to Enterobacteriaceae and Non-Fermenting Gram-Negative Bacilli Based on In Vitro Analysis at Two Community Hospitals |
title_sort | utility of combination antimicrobial therapy in adults with bloodstream infections due to enterobacteriaceae and non-fermenting gram-negative bacilli based on in vitro analysis at two community hospitals |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466593/ https://www.ncbi.nlm.nih.gov/pubmed/30744080 http://dx.doi.org/10.3390/antibiotics8010015 |
work_keys_str_mv | AT fosterrachela utilityofcombinationantimicrobialtherapyinadultswithbloodstreaminfectionsduetoenterobacteriaceaeandnonfermentinggramnegativebacillibasedoninvitroanalysisattwocommunityhospitals AT troficantocasey utilityofcombinationantimicrobialtherapyinadultswithbloodstreaminfectionsduetoenterobacteriaceaeandnonfermentinggramnegativebacillibasedoninvitroanalysisattwocommunityhospitals AT bookstaverpbrandon utilityofcombinationantimicrobialtherapyinadultswithbloodstreaminfectionsduetoenterobacteriaceaeandnonfermentinggramnegativebacillibasedoninvitroanalysisattwocommunityhospitals AT kohnjoseph utilityofcombinationantimicrobialtherapyinadultswithbloodstreaminfectionsduetoenterobacteriaceaeandnonfermentinggramnegativebacillibasedoninvitroanalysisattwocommunityhospitals AT justojulieann utilityofcombinationantimicrobialtherapyinadultswithbloodstreaminfectionsduetoenterobacteriaceaeandnonfermentinggramnegativebacillibasedoninvitroanalysisattwocommunityhospitals AT alhasanmajdin utilityofcombinationantimicrobialtherapyinadultswithbloodstreaminfectionsduetoenterobacteriaceaeandnonfermentinggramnegativebacillibasedoninvitroanalysisattwocommunityhospitals |